CLOV vs GALT · rev $1.37B vs $142.4M cap
Clover Health Investments Corp (CLOV) versus Galectin Therapeutics Inc (GALT) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Galectin Therapeutics Inc (GALT) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
GALT does not have a complete income-statement cache yet.
CLOV currently screens at market cap $1.55B. GALT currently screens at market cap $142.4M.
Not investment advice. Open the CLOV and GALT stock pages for the full models.
Not investment advice.